{"url_path":"/sec/oprx/8-k/2026-06-12/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ** **Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-12","source_url":"https://www.sec.gov/Archives/edgar/data/1448431/0001213900-26-068272-index.html","accession_number":"0001213900-26-068272","cik":"0001448431","ticker":"OPRX","issuer_name":"OptimizeRx Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1448431/0001213900-26-068272-index.html","primary_entity_key":"0001448431","primary_entity_name":"OptimizeRx Corp"},"word_count":86,"has_tables":true,"body_markdown":"**Item 9.01** **Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits.\n\n \n\n**Exhibit No.**\n \n**Description**\n\n10.1\n \n[Amendment No. 2 to the OptimizeRx 2021 Equity Incentive Plan](ea029456501ex10-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n2\n\n \n\n \n\nSIGNATURES\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.\n\n \n\n \nOPTIMIZERX CORPORATION\n\n \n \n\nDate: June 12, 2026\nBy:\n/s/ Marion Odence-Ford\n\n \n \nName: \nMarion Odence-Ford\n\n \n \nTitle:\nChief Legal & Administrative Officer\n\n \n\n \n\n3"}